GlaxoSmithKline plc (GLAXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:50AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 83.51B |
| Enterprise value | 99.74B |
| Trailing P/E | 13.30 |
| Forward P/E | 10.15 |
| PEG ratio (5-yr expected) | 1.07 |
| Price/sales (ttm) | 2.16 |
| Price/book (mrq) | 4.88 |
| Enterprise value/revenue | 3.29 |
| Enterprise value/EBITDA | 10.98 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.27 |
| 52-week change 3 | 11.89% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 22.12 |
| 52-week low 3 | 16.65 |
| 50-day moving average 3 | 20.89 |
| 200-day moving average 3 | 18.84 |
Share statistics
| Avg vol (3-month) 3 | 1.31k |
| Avg vol (10-day) 3 | 520 |
| Shares outstanding 5 | 4.09B |
| Implied shares outstanding 6 | 4.19B |
| Float 8 | 3.91B |
| % held by insiders 1 | 1.77% |
| % held by institutions 1 | 45.26% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 4.04% |
| Trailing annual dividend rate 3 | 0.58 |
| Trailing annual dividend yield 3 | 2.92% |
| 5-year average dividend yield 4 | 5.00 |
| Payout ratio 4 | 46.50% |
| Dividend date 3 | 10 Oct 2019 |
| Ex-dividend date 4 | 22 Feb 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 16.25% |
| Operating margin (ttm) | 20.35% |
Management effectiveness
| Return on assets (ttm) | 8.81% |
| Return on equity (ttm) | 46.38% |
Income statement
| Revenue (ttm) | 30.33B |
| Revenue per share (ttm) | 7.49 |
| Quarterly revenue growth (yoy) | 9.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 10.3B |
| Net income avi to common (ttm) | 4.93B |
| Diluted EPS (ttm) | 1.49 |
| Quarterly earnings growth (yoy) | -76.60% |
Balance sheet
| Total cash (mrq) | 5.69B |
| Total cash per share (mrq) | 1.4 |
| Total debt (mrq) | 18.02B |
| Total debt/equity (mrq) | 140.82% |
| Current ratio (mrq) | 0.88 |
| Book value per share (mrq) | 3.29 |
Cash flow statement
| Operating cash flow (ttm) | 6.77B |
| Levered free cash flow (ttm) | 3.56B |
© 2024 Yahoo. All rights reserved.